Inactive Instrument

Mill City Gold Corp Share Price Toronto S.E.

Equities

MC

CA5998052073

Pharmaceuticals

Financials

Sales 2022	-	Sales 2023	-	Capitalization	86.88 118.5 6.78K
Net income 2022	- 0 0	Net income 2023	- 0 0	EV / Sales 2022	-
Net Debt 2022	415K 566K 32.4M	Net Debt 2023	488K 666K 38.13M	EV / Sales 2023	-
P/E ratio 2022	-0.12 x	P/E ratio 2023	-	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	33.36%

More Fundamentals * Assessed data

Chart Mill City Gold Corp

Duration

Period

Style

Dynamic Chart

Latest news about Mill City Gold Corp

Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-26	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-28	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28/08/23	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/05/23	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	25/04/23	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	28/11/22	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	26/08/22	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/05/22	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	29/04/22	CI
Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	28/04/22	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	29/11/21	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	30/08/21	CI
Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/05/21	CI

More news

Managers and Directors - Mill City Gold Corp

Managers	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	30/10/02
Janice Brown BRD	Director/Board Member	-	31/10/02

Members of the board	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	30/10/02
Janice Brown BRD	Director/Board Member	-	31/10/02
Herbert Leary BRD	Director/Board Member	-	24/10/10

More insiders

Company Profile

Capha Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in exploring various opportunities in the medical technology space.

Sector

Pharmaceuticals

Calendar

25/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+56.89%	823B
NOVO NORDISK A/S	+39.52%	627B
JOHNSON & JOHNSON	-6.55%	353B
MERCK & CO., INC.	+15.99%	320B
ABBVIE INC.	+7.92%	295B
ASTRAZENECA PLC	+13.74%	239B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	167B